Instytut Fizjoterapii I BiotechnologiiP.S.A.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2024-09-24
Share capital
2,069,253.86 PLN
Registered address
pl. Jana Kilińskiego 2, 35-005 Rzeszów, Poland
Electronic delivery address
AE:PL-29652-34773-BUDCG-24
Financials
Revenue history (in k)
Filing timeliness
1 of 2 financial statements was filed late (for 2024, 94 days late).
- 202515/07/2026
- 202417/10/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 228.55kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 24.91kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 192.86kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 859.18kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Aleksandra Cichosz – Dyrektor Zarządzający
Manner of representation
Each director is authorized to submit declarations of will on behalf of the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-04-18.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 4, 2024 | Transformation |
Public aid
14 public aid cases recorded, with a total value of $262,852.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 30, 2026 | Training aid | $30,632$30,632 | Marszałek Województwa Podkarpackiego | |
| Feb 26, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,833$3,833 | Rzeszowska Agencja Rozwoju Regionalnego S.A. | |
| Aug 7, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $86,378$86,378 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-04-01 | Increasing the innovation capacity of Instytut fizjoterapii i biotechnologii Prosta Spółka Akcyjna by enhancing employee competencies | $30,632$30,632 | European Funds for Podkarpacie 2021-2027 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wstechnologysp. z o.o. | $258,318.71 | wstechnology.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| UveraS.A. | $155,384.29 | uvera.eu |
FAQ
Last updated: 2026-07-15